SCHOTT North America Lays Foundation to Maximize Market Opportunity
02 December 2021, Rye Brook, United States
- Setting a strategic portfolio in the U.S., SCHOTT aims to capitalize on the world’s largest economy and burgeoning capacity for innovation.
SCHOTT, the inventor of specialty glass and international technology group, is structuring its presence in North America to align operations with its most robust sales market and accelerate global profitability.
SCHOTT’s Pharmaceutical Systems business unit in Lebanon, Pa. contributed to the global COVID-19 response, increasing manufacturing capacity to serve the needs of vaccine makers. In addition, the Pennsylvania plant supplies the growing demand of high-value products such as adaptiQ® ready-to-use vials and EVERIC® pure for highly potent drugs like cancer medication. As part of a multimillion-dollar investment in the U.S. this past fiscal year, the facility saw upgrades and expanded capacity for vial production.
Pioneering – responsibly – together
These attributes characterize SCHOTT as a manufacturer of high-tech materials based on specialty glass. Founder Otto Schott is considered its inventor and became the pioneer of an entire industry. Always opening up new markets and applications with a pioneering spirit and passion – this is what has driven the #glasslovers at SCHOTT for more than 130 years. Represented in 34 countries, the company is a highly skilled partner for high-tech industries: Healthcare, Home Appliances & Living, Consumer Electronics, Semiconductors & Datacom, Optics, Industry & Energy, Automotive, Astronomy, and Aerospace. In the fiscal year 2020, its 16,500 employees generated sales of 2.24 billion euros. With the best teams, supported by the best digital tools, the group intends to continue to grow. SCHOTT AG is owned by the Carl Zeiss Foundation, one of the oldest foundations in Germany. It uses the Group's dividends to promote science. As a foundation company, SCHOTT has anchored responsibility for employees, society and the environment deeply in its DNA. The goal is to become a climate-neutral company by 2030.
Head of Corporate Communications